As on February 10, 2021, Agenus Inc. (NASDAQ: AGEN) started slowly as it slid -1.91% to $5.14. During the day, the stock rose to $5.3693 and sunk to $4.94 before settling in for the price of $5.24 at the close. Taking a more long-term approach, AGEN posted a 52-week range of $1.82-$5.95.
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was 84.70%. Meanwhile, its Annual Earning per share during the time was -2.30%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 44.60%. This publicly-traded company’s shares outstanding now amounts to $182.67 million, simultaneously with a float of $170.64 million. The organization now has a market capitalization sitting at $981.17 million. At the time of writing, stock’s 50-day Moving Average stood at $3.67, while the 200-day Moving Average is $3.73.
If we measure the efficiency of the company that is accounted for 328 employees. It has generated 125,114 per worker during the last fiscal year. Meanwhile, its income per employee was -543,170. The stock had 35.49 Receivables turnover and 0.27 Total Asset turnover. For the Profitability, stocks operating margin was -340.25 and Pretax Margin of -440.53.
Agenus Inc. (AGEN) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. Agenus Inc.’s current insider ownership accounts for 0.20%, in contrast to 53.50% institutional ownership. According to the most recent insider trade that took place on Jun 17, this organization’s 10% Owner sold 141,920 shares at the rate of 3.66, making the entire transaction reach 518,831 in total value, affecting insider ownership by 16,972,968. Preceding that transaction, on Jun 16, Company’s 10% Owner sold 72,080 for 3.66, making the whole transaction’s value amount to 264,007. This particular insider is now the holder of 17,114,888 in total.
Agenus Inc. (AGEN) Earnings and Revenue Records
If we go through the results of last quarter, which was made public on 9/29/2020, the company posted -$0.28 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -$0.26) by -$0.02. This company achieved a net margin of -434.14. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.24 per share during the current fiscal year.
Agenus Inc.’s EPS increase for this current 12-month fiscal period is 44.60% and is forecasted to reach -1.06 in the upcoming year.
Agenus Inc. (NASDAQ: AGEN) Trading Performance Indicators
Let’s observe the current performance indicators for Agenus Inc. (AGEN). The Stock has managed to achieve an average true range (ATR) of 0.38. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 10.73.
In the same vein, AGEN’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.09, a figure that is expected to reach -0.22 in the next quarter, and analysts are predicting that it will be -1.06 at the market close of one year from today.
Technical Analysis of Agenus Inc. (AGEN)
Through scrutinizing the latest numbers posted by the [Agenus Inc., AGEN], it can be observed that its last 5-days Average volume of 8.22 million was better the volume of 3.47 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 68.78% While, its Average True Range was 0.44.
Raw Stochastic average of Agenus Inc. (AGEN) in the period of the previous 100 days is set at 71.68%, which indicates a major rise in contrast to 69.20% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 90.02% that was higher than 64.82% volatility it exhibited in the past 100-days period.